• LAST PRICE
    51.1000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    20.5400/ 1
  • Ask / Lots
    55.6000/ 1
  • Open / Previous Close
    --- / 51.1000
  • Day Range
    ---
  • 52 Week Range
    Low 25.3500
    High 55.7800
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 50.75
TimeVolumeCRNX
09:32 ET269350.7
09:34 ET60050.439325
09:36 ET99650.435
09:38 ET120050.695
09:39 ET53250.745
09:41 ET40050.705
09:43 ET77550.7
09:45 ET243951.1
09:48 ET191951.29
09:50 ET1078351.73
09:52 ET40051.68
09:54 ET110051.12
09:56 ET119551.19
09:57 ET290051.47
09:59 ET10051.34
10:01 ET30051.445
10:03 ET151051.61
10:06 ET1250651.555
10:08 ET240451.72
10:10 ET130651.77
10:12 ET30051.755
10:14 ET372251.77
10:15 ET50051.76
10:17 ET126851.76
10:19 ET88451.74
10:21 ET30051.77
10:24 ET20051.715
10:26 ET37951.775
10:28 ET40051.83
10:32 ET181051.75
10:33 ET228651.71
10:35 ET20051.71
10:37 ET21951.755
10:39 ET20051.74
10:44 ET106451.67
10:46 ET12951.605
10:50 ET30051.5
10:53 ET1318251.56
10:55 ET20051.63
10:57 ET140051.54
11:02 ET20051.62
11:04 ET60051.705
11:06 ET64051.795
11:08 ET10051.785
11:09 ET45951.72
11:11 ET51151.66
11:13 ET10051.685
11:15 ET50051.74
11:18 ET50051.83
11:22 ET60051.855
11:24 ET40051.74
11:27 ET18351.72
11:29 ET89751.685
11:36 ET20051.6
11:38 ET20051.6
11:40 ET20051.6
11:42 ET50051.56
11:44 ET106751.6
11:45 ET25051.5351
11:47 ET120051.55
11:51 ET3105051.38
11:54 ET10051.4
11:56 ET20051.41
12:00 ET10051.4
12:03 ET345651.58
12:05 ET162151.63
12:07 ET30051.6
12:14 ET10551.57
12:16 ET10051.635
12:18 ET10051.675
12:20 ET50451.67
12:23 ET70851.73
12:25 ET40051.64
12:27 ET10051.61
12:34 ET10051.6
12:39 ET130951.62
12:41 ET60051.63
12:45 ET10051.635
12:48 ET46551.665
12:50 ET30351.6
12:52 ET40051.6
12:54 ET10051.58
12:56 ET10051.575
12:57 ET40051.48
12:59 ET1978851.49
01:01 ET110251.33
01:03 ET2127051.24
01:06 ET10051.215
01:10 ET20051.195
01:12 ET20051.25
01:14 ET10051.16
01:15 ET10051.235
01:17 ET76751.11
01:19 ET34551.07
01:21 ET40651.09
01:24 ET40051.06
01:28 ET30050.99
01:30 ET30050.91
01:33 ET10050.78
01:35 ET25550.775
01:39 ET1632951
01:44 ET280951.135
01:46 ET35051.095285
01:50 ET10051.11
01:51 ET30551.11
01:53 ET10051.11
01:57 ET50051.11
02:02 ET10051.145
02:04 ET33751.14
02:06 ET10051.14
02:08 ET363550.96
02:09 ET60051.01
02:11 ET10050.97
02:13 ET70050.82
02:15 ET40050.74
02:18 ET10050.78
02:22 ET330750.87
02:24 ET160050.75
02:26 ET130050.81
02:27 ET10550.78
02:31 ET60050.71
02:33 ET840950.76
02:38 ET160050.805
02:40 ET2193950.76
02:42 ET900050.79
02:44 ET30050.89
02:45 ET30050.93
02:47 ET69351.065
02:51 ET30051.11
02:54 ET91851.005
02:56 ET10050.965
02:58 ET10051.02
03:00 ET10050.97
03:02 ET20050.92
03:03 ET554350.84
03:05 ET41450.83
03:07 ET10050.79
03:14 ET180050.69
03:18 ET10050.65
03:20 ET30050.69
03:21 ET468050.69
03:23 ET10050.69
03:25 ET40050.67
03:27 ET202250.695
03:30 ET80050.695
03:32 ET78950.81
03:34 ET50050.87
03:36 ET91350.85
03:38 ET20050.855
03:39 ET30050.92
03:41 ET81250.86
03:43 ET140250.93
03:45 ET10250.9
03:48 ET40050.9
03:50 ET162850.96
03:52 ET132151.165
03:54 ET63351.03
03:56 ET30051.03
03:57 ET684751.18
03:59 ET8973151.1
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCRNX
Crinetics Pharmaceuticals Inc
4.1B
-13.6x
---
United StatesIMVT
Immunovant Inc
4.2B
-14.9x
---
United StatesDYN
Dyne Therapeutics Inc
3.6B
-10.0x
---
United StatesMDGL
Madrigal Pharmaceuticals Inc
4.6B
-8.3x
---
United StatesBHVN
Biohaven Ltd
4.7B
-5.5x
---
United StatesAPGE
Apogee Therapeutics Inc
3.4B
-26.2x
---
As of 2024-10-01

Company Information

Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.

Contact Information

Headquarters
10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
Phone
858-450-6464
Fax
302-636-5454

Executives

Independent Chairman of the Board
Wendell Wierenga
Co-Founder, Director
R. Scott Struthers
Co-Founder, Chief Scientific Officer
Stephen Betz
Chief Financial Officer
Marc Wilson
Chief Operating Officer
Jeff Knight

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.1B
Revenue (TTM)
$1.4M
Shares Outstanding
80.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.64
EPS
$-3.77
Book Value
$7.91
P/E Ratio
-13.6x
Price/Sales (TTM)
2,952.9
Price/Cash Flow (TTM)
---
Operating Margin
-20,068.38%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.